Heartland Advisors Inc Grifols Sa Transaction History

Heartland Advisors Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$10.21 - $15.27 $1.65 Million - $2.48 Million	-162,094 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$14.07 - $17.3 $426,771 - $524,743	-30,332 Reduced 15.76%	162,094 $2.37 Million
Q2 2021 Aug 11, 2021	BUY	$16.62 - $18.94 $3.2 Million - $3.64 Million	192,426 New	192,426 $3.34 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.1B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Heartland Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Heartland Advisors Inc with notifications on news.